Filing search / Ownership / Nuvectis Pharma, Inc.

8-K

NVCT Nuvectis Pharma, Inc.

5 Nov 24

Nuvectis Pharma, Inc. Reports Third Quarter 2024 Financial Results and Business Highlights

7:08am

8-K

NVCT Nuvectis Pharma, Inc.

29 Aug 24

Other Events

8:52am

8-K

NVCT Nuvectis Pharma, Inc.

6 Aug 24

Nuvectis Pharma, Inc. Reports Second Quarter 2024 Financial Results and Business Highlights

8:51am

8-K

7ouv7b6j

13 Jun 24

Submission of Matters to a Vote of Security Holders

4:09pm

8-K

g7iowb 2tv9zaxv69

7 May 24

Nuvectis Pharma, Inc. Reports First Quarter 2024 Financial Results and Business Highlights

9:13am

DEFA14A

5hc9wtje a5gr3

29 Apr 24

Additional proxy soliciting materials

4:33pm

8-K

ag2 bsivq9nyur5bwd

5 Mar 24

Nuvectis Pharma, Inc. Reports Fiscal Year 2023 Financial Results and Business Highlights

8:17am

8-K

mumv b4ns

8 Nov 23

Nuvectis Pharma, Inc. Reports Third Quarter 2023 Financial Results and Business Highlights

8:39am

8-K

k8puv phrjwo0r82w4

12 Sep 23

Nuvectis Pharma Announces Initiation of the NXP900 Phase 1a Clinical Trial

8:16am

8-K

ocm cyvho

17 Aug 23

Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA to NXP800 for the Treatment of Cholangiocarcinoma

9:18am

S-8

xgtip lwn1i0wotex

9 Aug 23

Registration of securities for employees

4:51pm

8-K

rm5289t6go7w

9 Aug 23

Nuvectis Pharma, Inc. Reports Second Quarter 2023 Financial Results and Business Highlights

4:29pm

8-K

bc3g0 owaxw

3 Jul 23

Results of Operations and Financial Condition

8:00am